EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Improved Antineoplastic Activity of Thermophilic L-Asparaginase Tli10209 via Site-Directed Mutagenesis

Lijuan Zhang, Simeng Ding, Xiuhui Tang, Renjun Gao iD, Rui Huo, Guiqiu Xie

Biomolecules · 2024

DOI: 10.3390/biom14060686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Lijuan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. Hauptthemen laut MEDLINE: Asparaginase, Antineoplastic Agents, Mutagenesis, Site-Directed. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, High Performance Computing Center of Jilin University, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amino acid deprivation therapy (AADT) is a novel anticancer therapy, considered nontoxic and selective. Thermophilic L-asparaginase enzymes display high stability and activity at elevated temperatures. However, they are of limited use in clinical applications because of their low substrate affinity and reduced activity under physiological conditions, which may necessitate an improved dosage, leading to side effects and greater costs. Thus, in an attempt to improve the activity of L-Asn at 37 °C, with the use of a semi-rational design, eight active-site mutants of Thermococcus litoralis DSM 5473 L-asparaginase Tli10209 were developed. T70A exhibited a 5.11-fold increase compared with the wild enzyme in physiological conditions. Double-mutant enzymes were created by combining mutants with higher hydrolysis activity. T70A/F36Y, T70A/K48L, and T70A/D50G were enhanced by 5.59-, 6.38-, and 5.58-fold. The immobilized enzyme applied in MCF-7 breast cancer cells only required one-seventh of the dose of the free enzyme to achieve the same inhibition rate under near-infrared irradiation. This provides a proof of concept that it is possible to reduce the consumption of L-Asn by improving its activity, thus providing a method to manage side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsparaginaseAntineoplastic AgentsMutagenesis, Site-DirectedHumansMCF-7 CellsThermococcusCatalytic Domain

Stichwörter der Autor:innen

L-asparaginaseantitumorgold nanorodsimmobilizationtargeted mutagenesis

Substanzen

AsparaginaseAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
  • Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Science, Jilin University, Changchun 130021, China.

ORCID-Profile: Renjun Gao

Förderung

  • National Natural Science Foundation of China
  • High Performance Computing Center of Jilin University, China

Zitieren

APA

Zhang, L., Ding, S., Tang, X., Gao, R., Huo, R., & Xie, G. (2024). The Improved Antineoplastic Activity of Thermophilic L-Asparaginase Tli10209 via Site-Directed Mutagenesis. Biomolecules. https://doi.org/10.3390/biom14060686

Vancouver

Zhang L, Ding S, Tang X, Gao R, Huo R, Xie G. The Improved Antineoplastic Activity of Thermophilic L-Asparaginase Tli10209 via Site-Directed Mutagenesis. Biomolecules. 2024. doi:10.3390/biom14060686

BibTeX
@article{Zhang2024,
  author = {Zhang, Lijuan and Ding, Simeng and Tang, Xiuhui and Gao, Renjun and Huo, Rui and Xie, Guiqiu},
  title = {The Improved Antineoplastic Activity of Thermophilic L-Asparaginase Tli10209 via Site-Directed Mutagenesis},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14060686}
}
Kostenlos starten →